The company was originally incorporated as CUVEST Pharmaceuticals. From its inception in 1950, CUVEST has specialized in the marketing and distribution of finished pharmaceutical and biological products. Among its first principals were Wyeth Laboratories, Armour Pharmaceuticals, Institut Merieux, and Institut Pasteur. All have since assumed domestic marketing and distribution of their respective products after CUVEST's trailblazing efforts to make their products market leaders. The later principals represented were Bausch & Lomb (USA), Dexxon (Israel), Egis (Hungary), G. Richter (Hungary) and Solco (Switzerland).

In 1988, a second company called PharmAsia, Inc. was formed specifically to market to hospitals and the government sector. It had its own field force and office staff. The companies it represented were Astrapin (Germany) and Stada (Germany).

Notwithstanding the success of both companies, the Board of Directors decided to merge CUVEST and PharmAsia at the end of 2000. Both companies stood to benefit from improved operational efficiency, as well as complementation in marketing activities.

Thus, in January of 2001, a new company called PharmAsia-Cuvest, Inc. was formed out of the merger. Both ownership and top management structure remained essentially unchanged.

PharmAsia-Cuvest, Inc. continues to represent and distribute high quality off-patent pharmaceuticals manufactured by its principals in Europe and in Asia.

Currently in the process of being organized is our CONSUMER HEALTH DIVISION.Its vision is to provide the Filipino customer and patient with direct access to truly innovative and beneficial health and cosmetic products.